UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.479

Sortiert nach

Family history and the risk of gastric cancer

British journal of cancer, 2010-01, Vol.102 (2), p.237-242

2010

Volltextzugriff (PDF)

Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients

Breast cancer research and treatment, 2014-09, Vol.147 (2), p.401-405

2014

Volltextzugriff (PDF)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

British journal of cancer, 2012-12, Vol.107 (12), p.2005-2009

2012

Volltextzugriff (PDF)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

British journal of cancer, 2008-04, Vol.98 (8), p.1457-1466

2008

Volltextzugriff (PDF)

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

Breast cancer research and treatment, 2015-05, Vol.151 (1), p.169-176

2015

Volltextzugriff (PDF)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

British journal of cancer, 2007-12, Vol.97 (12), p.1690-1695

2007

Volltextzugriff (PDF)

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

Breast cancer research and treatment, 2009-05, Vol.115 (2), p.359-363

2009

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutations and the risk for colorectal cancer

Clinical genetics, 2015-05, Vol.87 (5), p.411-418

2015

Volltextzugriff (PDF)

Testing for CHEK2 in the cancer genetics clinic: ready for prime time?

Clinical genetics, 2010-07, Vol.78 (1), p.1-7

Narod, SA

2010

Volltextzugriff (PDF)

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations

British journal of cancer, 2012-06, Vol.107 (1), p.24-30

2012

Volltextzugriff (PDF)

CHEK2 Is a Multiorgan Cancer Susceptibility Gene

American journal of human genetics, 2004-12, Vol.75 (6), p.1131-1135

2004

Volltextzugriff (PDF)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

British journal of cancer, 2011-04, Vol.104 (9), p.1384-1392

2011

Volltextzugriff (PDF)

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer

British journal of cancer, 2014-09, Vol.111 (6), p.1238-1240

2014

Volltextzugriff (PDF)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

British journal of cancer, 2014-01, Vol.110 (2), p.530-534

2014

Volltextzugriff (PDF)

Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy

Annals of oncology, 2013-06, Vol.24 (6), p.1498-1505

2013

Volltextzugriff (PDF)

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

Breast cancer research and treatment, 2015-04, Vol.150 (2), p.389-394

2015

Volltextzugriff (PDF)

Rapid progression of prostate cancer in men with a BRCA2 mutation

British journal of cancer, 2008-07, Vol.99 (2), p.371-374

2008

Volltextzugriff (PDF)

Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer

Journal of clinical oncology, 2001-08, Vol.19 (15), p.3524-3531

2001

Volltextzugriff (PDF)

A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing

British journal of cancer, 2013-08, Vol.109 (3), p.777-779

2013

Volltextzugriff (PDF)

BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane

British journal of cancer, 2014-09, Vol.111 (7), p.1269-1274

2014

Volltextzugriff (PDF)

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer

British journal of cancer, 2012-11, Vol.107 (10), p.1783-1790

2012

Volltextzugriff (PDF)

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 1999-09, Vol.91 (17), p.1475-1479

1999

Volltextzugriff (PDF)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

Clinical genetics, 2015-10, Vol.88 (4), p.371-375

2015

Volltextzugriff (PDF)

Diet, lifestyle and BRCA-related breast cancer risk among French-canadians

Breast cancer research and treatment, 2006-08, Vol.98 (3), p.285-294

2006

Volltextzugriff (PDF)

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

Breast cancer research and treatment, 2008-03, Vol.108 (2), p.289-296

2008

Volltextzugriff (PDF)

1 – 25 von 1.479

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.414)
Mit Volltextzugriff
(1.325)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Family history and the risk of gastric cancer

Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

BRCA1 and BRCA2 mutations and the risk for colorectal cancer

Testing for CHEK2 in the cancer genetics clinic: ready for prime time?

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations

CHEK2 Is a Multiorgan Cancer Susceptibility Gene

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

Rapid progression of prostate cancer in men with a BRCA2 mutation

Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer

A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing

BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer

Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

Diet, lifestyle and BRCA-related breast cancer risk among French-canadians

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

Suchergebnisse filtern